Global Protein Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities
The Protein Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Protein Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Protein Drugs market.
Major players in the global Protein Drugs market include:
Medimmune
Allergan
Affymax
Protein sciences corporation
Mylan
Amgen
Johnson & johnson
Btg international
Dendreon
Biotest pharmaceuticals
Hospira
Eisai
Alexion pharmaceuticals
Eli lilly
Baxter healthcare
Bio products laboratory
Csl
Bristol-myers squibb
Fresenius kabi
Octapharma pharmazeutika produktionsges.m.b.h
Kamada
Grifols biologicals
Bayer healthcare pharmaceuticals
Novartis
Novo nordisk
Abbott laboratories
Alcon
Omrix biopharmaceuticals
Biogen
Nabi biopharmaceuticals (now biota pharmaceuticals)
Merck
Pfizer
Boehringer ingelheim
Hoffman-la-roche
Ferring pharmaceuticals
Lundbeck
Cangene
Glaxosmithkline
Janssen-cilag
Kedrion biopharmaceuticals, spa
On the basis of types, the Protein Drugs market is primarily split into:
Cytokines
Antibodies
Blood products
Peptide antibiotics
Vaccines
Enzymes
Peptide hormones
On the basis of applications, the market covers:
Application 1
Application 2
Application 3
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Protein Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Protein Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Protein Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Protein Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Protein Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Protein Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Protein Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Protein Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
The report mainly studies the size, recent trends and development status of the Protein Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Protein Drugs market.
Major players in the global Protein Drugs market include:
Medimmune
Allergan
Affymax
Protein sciences corporation
Mylan
Amgen
Johnson & johnson
Btg international
Dendreon
Biotest pharmaceuticals
Hospira
Eisai
Alexion pharmaceuticals
Eli lilly
Baxter healthcare
Bio products laboratory
Csl
Bristol-myers squibb
Fresenius kabi
Octapharma pharmazeutika produktionsges.m.b.h
Kamada
Grifols biologicals
Bayer healthcare pharmaceuticals
Novartis
Novo nordisk
Abbott laboratories
Alcon
Omrix biopharmaceuticals
Biogen
Nabi biopharmaceuticals (now biota pharmaceuticals)
Merck
Pfizer
Boehringer ingelheim
Hoffman-la-roche
Ferring pharmaceuticals
Lundbeck
Cangene
Glaxosmithkline
Janssen-cilag
Kedrion biopharmaceuticals, spa
On the basis of types, the Protein Drugs market is primarily split into:
Cytokines
Antibodies
Blood products
Peptide antibiotics
Vaccines
Enzymes
Peptide hormones
On the basis of applications, the market covers:
Application 1
Application 2
Application 3
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
- United States
- Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
- China
- Japan
- India
- Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
- Central and South America (Brazil, Mexico, Colombia)
- Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
- Other Regions
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Protein Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Protein Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Protein Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Protein Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Protein Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Protein Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Protein Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Protein Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
- Historical Years: 2014-2018
- Base Year: 2019
- Estimated Year: 2019
- Forecast Period: 2019-2026
1 PROTEIN DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Protein Drugs
1.2 Protein Drugs Segment by Type
1.2.1 Global Protein Drugs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Cytokines
1.2.3 The Market Profile of Antibodies
1.2.4 The Market Profile of Blood products
1.2.5 The Market Profile of Peptide antibiotics
1.2.6 The Market Profile of Vaccines
1.2.7 The Market Profile of Enzymes
1.2.8 The Market Profile of Peptide hormones
1.3 Global Protein Drugs Segment by Application
1.3.1 Protein Drugs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Application
1.3.3 The Market Profile of Application
1.3.4 The Market Profile of Application
1.4 Global Protein Drugs Market by Region (2014-2026)
1.4.1 Global Protein Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Protein Drugs Market Status and Prospect (2014-2026)
1.4.3 Europe Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.2 UK Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.3 France Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Protein Drugs Market Status and Prospect (2014-2026)
1.4.4 China Protein Drugs Market Status and Prospect (2014-2026)
1.4.5 Japan Protein Drugs Market Status and Prospect (2014-2026)
1.4.6 India Protein Drugs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Protein Drugs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Protein Drugs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Protein Drugs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Protein Drugs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Protein Drugs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Protein Drugs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Protein Drugs (2014-2026)
1.5.1 Global Protein Drugs Revenue Status and Outlook (2014-2026)
1.5.2 Global Protein Drugs Production Status and Outlook (2014-2026)
2 GLOBAL PROTEIN DRUGS MARKET LANDSCAPE BY PLAYER
2.1 Global Protein Drugs Production and Share by Player (2014-2019)
2.2 Global Protein Drugs Revenue and Market Share by Player (2014-2019)
2.3 Global Protein Drugs Average Price by Player (2014-2019)
2.4 Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Protein Drugs Market Competitive Situation and Trends
2.5.1 Protein Drugs Market Concentration Rate
2.5.2 Protein Drugs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Medimmune
3.1.1 Medimmune Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Protein Drugs Product Profiles, Application and Specification
3.1.3 Medimmune Protein Drugs Market Performance (2014-2019)
3.1.4 Medimmune Business Overview
3.2 Allergan
3.2.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Protein Drugs Product Profiles, Application and Specification
3.2.3 Allergan Protein Drugs Market Performance (2014-2019)
3.2.4 Allergan Business Overview
3.3 Affymax
3.3.1 Affymax Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Protein Drugs Product Profiles, Application and Specification
3.3.3 Affymax Protein Drugs Market Performance (2014-2019)
3.3.4 Affymax Business Overview
3.4 Protein sciences corporation
3.4.1 Protein sciences corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Protein Drugs Product Profiles, Application and Specification
3.4.3 Protein sciences corporation Protein Drugs Market Performance (2014-2019)
3.4.4 Protein sciences corporation Business Overview
3.5 Mylan
3.5.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Protein Drugs Product Profiles, Application and Specification
3.5.3 Mylan Protein Drugs Market Performance (2014-2019)
3.5.4 Mylan Business Overview
3.6 Amgen
3.6.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Protein Drugs Product Profiles, Application and Specification
3.6.3 Amgen Protein Drugs Market Performance (2014-2019)
3.6.4 Amgen Business Overview
3.7 Johnson & johnson
3.7.1 Johnson & johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Protein Drugs Product Profiles, Application and Specification
3.7.3 Johnson & johnson Protein Drugs Market Performance (2014-2019)
3.7.4 Johnson & johnson Business Overview
3.8 Btg international
3.8.1 Btg international Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Protein Drugs Product Profiles, Application and Specification
3.8.3 Btg international Protein Drugs Market Performance (2014-2019)
3.8.4 Btg international Business Overview
3.9 Dendreon
3.9.1 Dendreon Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Protein Drugs Product Profiles, Application and Specification
3.9.3 Dendreon Protein Drugs Market Performance (2014-2019)
3.9.4 Dendreon Business Overview
3.10 Biotest pharmaceuticals
3.10.1 Biotest pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Protein Drugs Product Profiles, Application and Specification
3.10.3 Biotest pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.10.4 Biotest pharmaceuticals Business Overview
3.11 Hospira
3.11.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Protein Drugs Product Profiles, Application and Specification
3.11.3 Hospira Protein Drugs Market Performance (2014-2019)
3.11.4 Hospira Business Overview
3.12 Eisai
3.12.1 Eisai Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Protein Drugs Product Profiles, Application and Specification
3.12.3 Eisai Protein Drugs Market Performance (2014-2019)
3.12.4 Eisai Business Overview
3.13 Alexion pharmaceuticals
3.13.1 Alexion pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Protein Drugs Product Profiles, Application and Specification
3.13.3 Alexion pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.13.4 Alexion pharmaceuticals Business Overview
3.14 Eli lilly
3.14.1 Eli lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Protein Drugs Product Profiles, Application and Specification
3.14.3 Eli lilly Protein Drugs Market Performance (2014-2019)
3.14.4 Eli lilly Business Overview
3.15 Baxter healthcare
3.15.1 Baxter healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Protein Drugs Product Profiles, Application and Specification
3.15.3 Baxter healthcare Protein Drugs Market Performance (2014-2019)
3.15.4 Baxter healthcare Business Overview
3.16 Bio products laboratory
3.16.1 Bio products laboratory Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Protein Drugs Product Profiles, Application and Specification
3.16.3 Bio products laboratory Protein Drugs Market Performance (2014-2019)
3.16.4 Bio products laboratory Business Overview
3.17 Csl
3.17.1 Csl Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Protein Drugs Product Profiles, Application and Specification
3.17.3 Csl Protein Drugs Market Performance (2014-2019)
3.17.4 Csl Business Overview
3.18 Bristol-myers squibb
3.18.1 Bristol-myers squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Protein Drugs Product Profiles, Application and Specification
3.18.3 Bristol-myers squibb Protein Drugs Market Performance (2014-2019)
3.18.4 Bristol-myers squibb Business Overview
3.19 Fresenius kabi
3.19.1 Fresenius kabi Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Protein Drugs Product Profiles, Application and Specification
3.19.3 Fresenius kabi Protein Drugs Market Performance (2014-2019)
3.19.4 Fresenius kabi Business Overview
3.20 Octapharma pharmazeutika produktionsges.m.b.h
3.20.1 Octapharma pharmazeutika produktionsges.m.b.h Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Protein Drugs Product Profiles, Application and Specification
3.20.3 Octapharma pharmazeutika produktionsges.m.b.h Protein Drugs Market Performance (2014-2019)
3.20.4 Octapharma pharmazeutika produktionsges.m.b.h Business Overview
3.21 Kamada
3.21.1 Kamada Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Protein Drugs Product Profiles, Application and Specification
3.21.3 Kamada Protein Drugs Market Performance (2014-2019)
3.21.4 Kamada Business Overview
3.22 Grifols biologicals
3.22.1 Grifols biologicals Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Protein Drugs Product Profiles, Application and Specification
3.22.3 Grifols biologicals Protein Drugs Market Performance (2014-2019)
3.22.4 Grifols biologicals Business Overview
3.23 Bayer healthcare pharmaceuticals
3.23.1 Bayer healthcare pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Protein Drugs Product Profiles, Application and Specification
3.23.3 Bayer healthcare pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.23.4 Bayer healthcare pharmaceuticals Business Overview
3.24 Novartis
3.24.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Protein Drugs Product Profiles, Application and Specification
3.24.3 Novartis Protein Drugs Market Performance (2014-2019)
3.24.4 Novartis Business Overview
3.25 Novo nordisk
3.25.1 Novo nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.25.2 Protein Drugs Product Profiles, Application and Specification
3.25.3 Novo nordisk Protein Drugs Market Performance (2014-2019)
3.25.4 Novo nordisk Business Overview
3.26 Abbott laboratories
3.26.1 Abbott laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.26.2 Protein Drugs Product Profiles, Application and Specification
3.26.3 Abbott laboratories Protein Drugs Market Performance (2014-2019)
3.26.4 Abbott laboratories Business Overview
3.27 Alcon
3.27.1 Alcon Basic Information, Manufacturing Base, Sales Area and Competitors
3.27.2 Protein Drugs Product Profiles, Application and Specification
3.27.3 Alcon Protein Drugs Market Performance (2014-2019)
3.27.4 Alcon Business Overview
3.28 Omrix biopharmaceuticals
3.28.1 Omrix biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.28.2 Protein Drugs Product Profiles, Application and Specification
3.28.3 Omrix biopharmaceuticals Protein Drugs Market Performance (2014-2019)
3.28.4 Omrix biopharmaceuticals Business Overview
3.29 Biogen
3.29.1 Biogen Basic Information, Manufacturing Base, Sales Area and Competitors
3.29.2 Protein Drugs Product Profiles, Application and Specification
3.29.3 Biogen Protein Drugs Market Performance (2014-2019)
3.29.4 Biogen Business Overview
3.30 Nabi biopharmaceuticals (now biota pharmaceuticals)
3.30.1 Nabi biopharmaceuticals (now biota pharmaceuticals) Basic Information, Manufacturing Base, Sales Area and Competitors
3.30.2 Protein Drugs Product Profiles, Application and Specification
3.30.3 Nabi biopharmaceuticals (now biota pharmaceuticals) Protein Drugs Market Performance (2014-2019)
3.30.4 Nabi biopharmaceuticals (now biota pharmaceuticals) Business Overview
3.31 Merck
3.31.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.31.2 Protein Drugs Product Profiles, Application and Specification
3.31.3 Merck Protein Drugs Market Performance (2014-2019)
3.31.4 Merck Business Overview
3.32 Pfizer
3.32.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.32.2 Protein Drugs Product Profiles, Application and Specification
3.32.3 Pfizer Protein Drugs Market Performance (2014-2019)
3.32.4 Pfizer Business Overview
3.33 Boehringer ingelheim
3.33.1 Boehringer ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.33.2 Protein Drugs Product Profiles, Application and Specification
3.33.3 Boehringer ingelheim Protein Drugs Market Performance (2014-2019)
3.33.4 Boehringer ingelheim Business Overview
3.34 Hoffman-la-roche
3.34.1 Hoffman-la-roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.34.2 Protein Drugs Product Profiles, Application and Specification
3.34.3 Hoffman-la-roche Protein Drugs Market Performance (2014-2019)
3.34.4 Hoffman-la-roche Business Overview
3.35 Ferring pharmaceuticals
3.35.1 Ferring pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.35.2 Protein Drugs Product Profiles, Application and Specification
3.35.3 Ferring pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.35.4 Ferring pharmaceuticals Business Overview
3.36 Lundbeck
3.36.1 Lundbeck Basic Information, Manufacturing Base, Sales Area and Competitors
3.36.2 Protein Drugs Product Profiles, Application and Specification
3.36.3 Lundbeck Protein Drugs Market Performance (2014-2019)
3.36.4 Lundbeck Business Overview
3.37 Cangene
3.37.1 Cangene Basic Information, Manufacturing Base, Sales Area and Competitors
3.37.2 Protein Drugs Product Profiles, Application and Specification
3.37.3 Cangene Protein Drugs Market Performance (2014-2019)
3.37.4 Cangene Business Overview
3.38 Glaxosmithkline
3.38.1 Glaxosmithkline Basic Information, Manufacturing Base, Sales Area and Competitors
3.38.2 Protein Drugs Product Profiles, Application and Specification
3.38.3 Glaxosmithkline Protein Drugs Market Performance (2014-2019)
3.38.4 Glaxosmithkline Business Overview
3.39 Janssen-cilag
3.39.1 Janssen-cilag Basic Information, Manufacturing Base, Sales Area and Competitors
3.39.2 Protein Drugs Product Profiles, Application and Specification
3.39.3 Janssen-cilag Protein Drugs Market Performance (2014-2019)
3.39.4 Janssen-cilag Business Overview
3.40 Kedrion biopharmaceuticals, spa
3.40.1 Kedrion biopharmaceuticals, spa Basic Information, Manufacturing Base, Sales Area and Competitors
3.40.2 Protein Drugs Product Profiles, Application and Specification
3.40.3 Kedrion biopharmaceuticals, spa Protein Drugs Market Performance (2014-2019)
3.40.4 Kedrion biopharmaceuticals, spa Business Overview
4 GLOBAL PROTEIN DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Protein Drugs Production and Market Share by Type (2014-2019)
4.2 Global Protein Drugs Revenue and Market Share by Type (2014-2019)
4.3 Global Protein Drugs Price by Type (2014-2019)
4.4 Global Protein Drugs Production Growth Rate by Type (2014-2019)
4.4.1 Global Protein Drugs Production Growth Rate of Cytokines (2014-2019)
4.4.2 Global Protein Drugs Production Growth Rate of Antibodies (2014-2019)
4.4.3 Global Protein Drugs Production Growth Rate of Blood products (2014-2019)
4.4.4 Global Protein Drugs Production Growth Rate of Peptide antibiotics (2014-2019)
4.4.5 Global Protein Drugs Production Growth Rate of Vaccines (2014-2019)
4.4.6 Global Protein Drugs Production Growth Rate of Enzymes (2014-2019)
4.4.7 Global Protein Drugs Production Growth Rate of Peptide hormones (2014-2019)
5 GLOBAL PROTEIN DRUGS MARKET ANALYSIS BY APPLICATION
5.1 Global Protein Drugs Consumption and Market Share by Application (2014-2019)
5.2 Global Protein Drugs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Protein Drugs Consumption Growth Rate of Application 1 (2014-2019)
5.2.2 Global Protein Drugs Consumption Growth Rate of Application 2 (2014-2019)
5.2.3 Global Protein Drugs Consumption Growth Rate of Application 3 (2014-2019)
6 GLOBAL PROTEIN DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Protein Drugs Consumption by Region (2014-2019)
6.2 United States Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.6 India Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Protein Drugs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL PROTEIN DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Protein Drugs Production and Market Share by Region (2014-2019)
7.2 Global Protein Drugs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
8 PROTEIN DRUGS MANUFACTURING ANALYSIS
8.1 Protein Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Protein Drugs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Protein Drugs Industrial Chain Analysis
9.2 Raw Materials Sources of Protein Drugs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Protein Drugs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL PROTEIN DRUGS MARKET FORECAST (2019-2026)
11.1 Global Protein Drugs Production, Revenue Forecast (2019-2026)
11.1.1 Global Protein Drugs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Protein Drugs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Protein Drugs Price and Trend Forecast (2019-2026)
11.2 Global Protein Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Protein Drugs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Protein Drugs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Protein Drugs
1.2 Protein Drugs Segment by Type
1.2.1 Global Protein Drugs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Cytokines
1.2.3 The Market Profile of Antibodies
1.2.4 The Market Profile of Blood products
1.2.5 The Market Profile of Peptide antibiotics
1.2.6 The Market Profile of Vaccines
1.2.7 The Market Profile of Enzymes
1.2.8 The Market Profile of Peptide hormones
1.3 Global Protein Drugs Segment by Application
1.3.1 Protein Drugs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Application
1.3.3 The Market Profile of Application
1.3.4 The Market Profile of Application
1.4 Global Protein Drugs Market by Region (2014-2026)
1.4.1 Global Protein Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Protein Drugs Market Status and Prospect (2014-2026)
1.4.3 Europe Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.2 UK Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.3 France Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Protein Drugs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Protein Drugs Market Status and Prospect (2014-2026)
1.4.4 China Protein Drugs Market Status and Prospect (2014-2026)
1.4.5 Japan Protein Drugs Market Status and Prospect (2014-2026)
1.4.6 India Protein Drugs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Protein Drugs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Protein Drugs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Protein Drugs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Protein Drugs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Protein Drugs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Protein Drugs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Protein Drugs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Protein Drugs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Protein Drugs (2014-2026)
1.5.1 Global Protein Drugs Revenue Status and Outlook (2014-2026)
1.5.2 Global Protein Drugs Production Status and Outlook (2014-2026)
2 GLOBAL PROTEIN DRUGS MARKET LANDSCAPE BY PLAYER
2.1 Global Protein Drugs Production and Share by Player (2014-2019)
2.2 Global Protein Drugs Revenue and Market Share by Player (2014-2019)
2.3 Global Protein Drugs Average Price by Player (2014-2019)
2.4 Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Protein Drugs Market Competitive Situation and Trends
2.5.1 Protein Drugs Market Concentration Rate
2.5.2 Protein Drugs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Medimmune
3.1.1 Medimmune Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Protein Drugs Product Profiles, Application and Specification
3.1.3 Medimmune Protein Drugs Market Performance (2014-2019)
3.1.4 Medimmune Business Overview
3.2 Allergan
3.2.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Protein Drugs Product Profiles, Application and Specification
3.2.3 Allergan Protein Drugs Market Performance (2014-2019)
3.2.4 Allergan Business Overview
3.3 Affymax
3.3.1 Affymax Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Protein Drugs Product Profiles, Application and Specification
3.3.3 Affymax Protein Drugs Market Performance (2014-2019)
3.3.4 Affymax Business Overview
3.4 Protein sciences corporation
3.4.1 Protein sciences corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Protein Drugs Product Profiles, Application and Specification
3.4.3 Protein sciences corporation Protein Drugs Market Performance (2014-2019)
3.4.4 Protein sciences corporation Business Overview
3.5 Mylan
3.5.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Protein Drugs Product Profiles, Application and Specification
3.5.3 Mylan Protein Drugs Market Performance (2014-2019)
3.5.4 Mylan Business Overview
3.6 Amgen
3.6.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Protein Drugs Product Profiles, Application and Specification
3.6.3 Amgen Protein Drugs Market Performance (2014-2019)
3.6.4 Amgen Business Overview
3.7 Johnson & johnson
3.7.1 Johnson & johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Protein Drugs Product Profiles, Application and Specification
3.7.3 Johnson & johnson Protein Drugs Market Performance (2014-2019)
3.7.4 Johnson & johnson Business Overview
3.8 Btg international
3.8.1 Btg international Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Protein Drugs Product Profiles, Application and Specification
3.8.3 Btg international Protein Drugs Market Performance (2014-2019)
3.8.4 Btg international Business Overview
3.9 Dendreon
3.9.1 Dendreon Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Protein Drugs Product Profiles, Application and Specification
3.9.3 Dendreon Protein Drugs Market Performance (2014-2019)
3.9.4 Dendreon Business Overview
3.10 Biotest pharmaceuticals
3.10.1 Biotest pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Protein Drugs Product Profiles, Application and Specification
3.10.3 Biotest pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.10.4 Biotest pharmaceuticals Business Overview
3.11 Hospira
3.11.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Protein Drugs Product Profiles, Application and Specification
3.11.3 Hospira Protein Drugs Market Performance (2014-2019)
3.11.4 Hospira Business Overview
3.12 Eisai
3.12.1 Eisai Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Protein Drugs Product Profiles, Application and Specification
3.12.3 Eisai Protein Drugs Market Performance (2014-2019)
3.12.4 Eisai Business Overview
3.13 Alexion pharmaceuticals
3.13.1 Alexion pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Protein Drugs Product Profiles, Application and Specification
3.13.3 Alexion pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.13.4 Alexion pharmaceuticals Business Overview
3.14 Eli lilly
3.14.1 Eli lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Protein Drugs Product Profiles, Application and Specification
3.14.3 Eli lilly Protein Drugs Market Performance (2014-2019)
3.14.4 Eli lilly Business Overview
3.15 Baxter healthcare
3.15.1 Baxter healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Protein Drugs Product Profiles, Application and Specification
3.15.3 Baxter healthcare Protein Drugs Market Performance (2014-2019)
3.15.4 Baxter healthcare Business Overview
3.16 Bio products laboratory
3.16.1 Bio products laboratory Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Protein Drugs Product Profiles, Application and Specification
3.16.3 Bio products laboratory Protein Drugs Market Performance (2014-2019)
3.16.4 Bio products laboratory Business Overview
3.17 Csl
3.17.1 Csl Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Protein Drugs Product Profiles, Application and Specification
3.17.3 Csl Protein Drugs Market Performance (2014-2019)
3.17.4 Csl Business Overview
3.18 Bristol-myers squibb
3.18.1 Bristol-myers squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Protein Drugs Product Profiles, Application and Specification
3.18.3 Bristol-myers squibb Protein Drugs Market Performance (2014-2019)
3.18.4 Bristol-myers squibb Business Overview
3.19 Fresenius kabi
3.19.1 Fresenius kabi Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Protein Drugs Product Profiles, Application and Specification
3.19.3 Fresenius kabi Protein Drugs Market Performance (2014-2019)
3.19.4 Fresenius kabi Business Overview
3.20 Octapharma pharmazeutika produktionsges.m.b.h
3.20.1 Octapharma pharmazeutika produktionsges.m.b.h Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Protein Drugs Product Profiles, Application and Specification
3.20.3 Octapharma pharmazeutika produktionsges.m.b.h Protein Drugs Market Performance (2014-2019)
3.20.4 Octapharma pharmazeutika produktionsges.m.b.h Business Overview
3.21 Kamada
3.21.1 Kamada Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Protein Drugs Product Profiles, Application and Specification
3.21.3 Kamada Protein Drugs Market Performance (2014-2019)
3.21.4 Kamada Business Overview
3.22 Grifols biologicals
3.22.1 Grifols biologicals Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Protein Drugs Product Profiles, Application and Specification
3.22.3 Grifols biologicals Protein Drugs Market Performance (2014-2019)
3.22.4 Grifols biologicals Business Overview
3.23 Bayer healthcare pharmaceuticals
3.23.1 Bayer healthcare pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Protein Drugs Product Profiles, Application and Specification
3.23.3 Bayer healthcare pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.23.4 Bayer healthcare pharmaceuticals Business Overview
3.24 Novartis
3.24.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Protein Drugs Product Profiles, Application and Specification
3.24.3 Novartis Protein Drugs Market Performance (2014-2019)
3.24.4 Novartis Business Overview
3.25 Novo nordisk
3.25.1 Novo nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.25.2 Protein Drugs Product Profiles, Application and Specification
3.25.3 Novo nordisk Protein Drugs Market Performance (2014-2019)
3.25.4 Novo nordisk Business Overview
3.26 Abbott laboratories
3.26.1 Abbott laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.26.2 Protein Drugs Product Profiles, Application and Specification
3.26.3 Abbott laboratories Protein Drugs Market Performance (2014-2019)
3.26.4 Abbott laboratories Business Overview
3.27 Alcon
3.27.1 Alcon Basic Information, Manufacturing Base, Sales Area and Competitors
3.27.2 Protein Drugs Product Profiles, Application and Specification
3.27.3 Alcon Protein Drugs Market Performance (2014-2019)
3.27.4 Alcon Business Overview
3.28 Omrix biopharmaceuticals
3.28.1 Omrix biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.28.2 Protein Drugs Product Profiles, Application and Specification
3.28.3 Omrix biopharmaceuticals Protein Drugs Market Performance (2014-2019)
3.28.4 Omrix biopharmaceuticals Business Overview
3.29 Biogen
3.29.1 Biogen Basic Information, Manufacturing Base, Sales Area and Competitors
3.29.2 Protein Drugs Product Profiles, Application and Specification
3.29.3 Biogen Protein Drugs Market Performance (2014-2019)
3.29.4 Biogen Business Overview
3.30 Nabi biopharmaceuticals (now biota pharmaceuticals)
3.30.1 Nabi biopharmaceuticals (now biota pharmaceuticals) Basic Information, Manufacturing Base, Sales Area and Competitors
3.30.2 Protein Drugs Product Profiles, Application and Specification
3.30.3 Nabi biopharmaceuticals (now biota pharmaceuticals) Protein Drugs Market Performance (2014-2019)
3.30.4 Nabi biopharmaceuticals (now biota pharmaceuticals) Business Overview
3.31 Merck
3.31.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.31.2 Protein Drugs Product Profiles, Application and Specification
3.31.3 Merck Protein Drugs Market Performance (2014-2019)
3.31.4 Merck Business Overview
3.32 Pfizer
3.32.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.32.2 Protein Drugs Product Profiles, Application and Specification
3.32.3 Pfizer Protein Drugs Market Performance (2014-2019)
3.32.4 Pfizer Business Overview
3.33 Boehringer ingelheim
3.33.1 Boehringer ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.33.2 Protein Drugs Product Profiles, Application and Specification
3.33.3 Boehringer ingelheim Protein Drugs Market Performance (2014-2019)
3.33.4 Boehringer ingelheim Business Overview
3.34 Hoffman-la-roche
3.34.1 Hoffman-la-roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.34.2 Protein Drugs Product Profiles, Application and Specification
3.34.3 Hoffman-la-roche Protein Drugs Market Performance (2014-2019)
3.34.4 Hoffman-la-roche Business Overview
3.35 Ferring pharmaceuticals
3.35.1 Ferring pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.35.2 Protein Drugs Product Profiles, Application and Specification
3.35.3 Ferring pharmaceuticals Protein Drugs Market Performance (2014-2019)
3.35.4 Ferring pharmaceuticals Business Overview
3.36 Lundbeck
3.36.1 Lundbeck Basic Information, Manufacturing Base, Sales Area and Competitors
3.36.2 Protein Drugs Product Profiles, Application and Specification
3.36.3 Lundbeck Protein Drugs Market Performance (2014-2019)
3.36.4 Lundbeck Business Overview
3.37 Cangene
3.37.1 Cangene Basic Information, Manufacturing Base, Sales Area and Competitors
3.37.2 Protein Drugs Product Profiles, Application and Specification
3.37.3 Cangene Protein Drugs Market Performance (2014-2019)
3.37.4 Cangene Business Overview
3.38 Glaxosmithkline
3.38.1 Glaxosmithkline Basic Information, Manufacturing Base, Sales Area and Competitors
3.38.2 Protein Drugs Product Profiles, Application and Specification
3.38.3 Glaxosmithkline Protein Drugs Market Performance (2014-2019)
3.38.4 Glaxosmithkline Business Overview
3.39 Janssen-cilag
3.39.1 Janssen-cilag Basic Information, Manufacturing Base, Sales Area and Competitors
3.39.2 Protein Drugs Product Profiles, Application and Specification
3.39.3 Janssen-cilag Protein Drugs Market Performance (2014-2019)
3.39.4 Janssen-cilag Business Overview
3.40 Kedrion biopharmaceuticals, spa
3.40.1 Kedrion biopharmaceuticals, spa Basic Information, Manufacturing Base, Sales Area and Competitors
3.40.2 Protein Drugs Product Profiles, Application and Specification
3.40.3 Kedrion biopharmaceuticals, spa Protein Drugs Market Performance (2014-2019)
3.40.4 Kedrion biopharmaceuticals, spa Business Overview
4 GLOBAL PROTEIN DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Protein Drugs Production and Market Share by Type (2014-2019)
4.2 Global Protein Drugs Revenue and Market Share by Type (2014-2019)
4.3 Global Protein Drugs Price by Type (2014-2019)
4.4 Global Protein Drugs Production Growth Rate by Type (2014-2019)
4.4.1 Global Protein Drugs Production Growth Rate of Cytokines (2014-2019)
4.4.2 Global Protein Drugs Production Growth Rate of Antibodies (2014-2019)
4.4.3 Global Protein Drugs Production Growth Rate of Blood products (2014-2019)
4.4.4 Global Protein Drugs Production Growth Rate of Peptide antibiotics (2014-2019)
4.4.5 Global Protein Drugs Production Growth Rate of Vaccines (2014-2019)
4.4.6 Global Protein Drugs Production Growth Rate of Enzymes (2014-2019)
4.4.7 Global Protein Drugs Production Growth Rate of Peptide hormones (2014-2019)
5 GLOBAL PROTEIN DRUGS MARKET ANALYSIS BY APPLICATION
5.1 Global Protein Drugs Consumption and Market Share by Application (2014-2019)
5.2 Global Protein Drugs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Protein Drugs Consumption Growth Rate of Application 1 (2014-2019)
5.2.2 Global Protein Drugs Consumption Growth Rate of Application 2 (2014-2019)
5.2.3 Global Protein Drugs Consumption Growth Rate of Application 3 (2014-2019)
6 GLOBAL PROTEIN DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Protein Drugs Consumption by Region (2014-2019)
6.2 United States Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.6 India Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Protein Drugs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Protein Drugs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL PROTEIN DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Protein Drugs Production and Market Share by Region (2014-2019)
7.2 Global Protein Drugs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
8 PROTEIN DRUGS MANUFACTURING ANALYSIS
8.1 Protein Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Protein Drugs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Protein Drugs Industrial Chain Analysis
9.2 Raw Materials Sources of Protein Drugs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Protein Drugs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL PROTEIN DRUGS MARKET FORECAST (2019-2026)
11.1 Global Protein Drugs Production, Revenue Forecast (2019-2026)
11.1.1 Global Protein Drugs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Protein Drugs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Protein Drugs Price and Trend Forecast (2019-2026)
11.2 Global Protein Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Protein Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Protein Drugs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Protein Drugs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Protein Drugs Product Picture
Table Global Protein Drugs Production and CAGR (%) Comparison by Type
Table Profile of Cytokines
Table Profile of Antibodies
Table Profile of Blood products
Table Profile of Peptide antibiotics
Table Profile of Vaccines
Table Profile of Enzymes
Table Profile of Peptide hormones
Table Protein Drugs Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Application 1
Table Profile of Application 2
Table Profile of Application 3
Figure Global Protein Drugs Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Europe Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Germany Protein Drugs Revenue and Growth Rate (2014-2026)
Figure UK Protein Drugs Revenue and Growth Rate (2014-2026)
Figure France Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Italy Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Spain Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Russia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Poland Protein Drugs Revenue and Growth Rate (2014-2026)
Figure China Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Japan Protein Drugs Revenue and Growth Rate (2014-2026)
Figure India Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Malaysia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Singapore Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Philippines Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Indonesia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Thailand Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Vietnam Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Central and South America Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Brazil Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Mexico Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Colombia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Turkey Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Egypt Protein Drugs Revenue and Growth Rate (2014-2026)
Figure South Africa Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Nigeria Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Global Protein Drugs Production Status and Outlook (2014-2026)
Table Global Protein Drugs Production by Player (2014-2019)
Table Global Protein Drugs Production Share by Player (2014-2019)
Figure Global Protein Drugs Production Share by Player in 2018
Table Protein Drugs Revenue by Player (2014-2019)
Table Protein Drugs Revenue Market Share by Player (2014-2019)
Table Protein Drugs Price by Player (2014-2019)
Table Protein Drugs Manufacturing Base Distribution and Sales Area by Player
Table Protein Drugs Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Medimmune Profile
Table Medimmune Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Allergan Profile
Table Allergan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Affymax Profile
Table Affymax Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Protein sciences corporation Profile
Table Protein sciences corporation Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Mylan Profile
Table Mylan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Amgen Profile
Table Amgen Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Johnson & johnson Profile
Table Johnson & johnson Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Btg international Profile
Table Btg international Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Dendreon Profile
Table Dendreon Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Biotest pharmaceuticals Profile
Table Biotest pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Hospira Profile
Table Hospira Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Eisai Profile
Table Eisai Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Alexion pharmaceuticals Profile
Table Alexion pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Eli lilly Profile
Table Eli lilly Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Baxter healthcare Profile
Table Baxter healthcare Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Bio products laboratory Profile
Table Bio products laboratory Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Csl Profile
Table Csl Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-myers squibb Profile
Table Bristol-myers squibb Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Fresenius kabi Profile
Table Fresenius kabi Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Octapharma pharmazeutika produktionsges.m.b.h Profile
Table Octapharma pharmazeutika produktionsges.m.b.h Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Kamada Profile
Table Kamada Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Grifols biologicals Profile
Table Grifols biologicals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Bayer healthcare pharmaceuticals Profile
Table Bayer healthcare pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis Profile
Table Novartis Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Novo nordisk Profile
Table Novo nordisk Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Abbott laboratories Profile
Table Abbott laboratories Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Alcon Profile
Table Alcon Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Omrix biopharmaceuticals Profile
Table Omrix biopharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Biogen Profile
Table Biogen Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Nabi biopharmaceuticals (now biota pharmaceuticals) Profile
Table Nabi biopharmaceuticals (now biota pharmaceuticals) Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Profile
Table Merck Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Boehringer ingelheim Profile
Table Boehringer ingelheim Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Hoffman-la-roche Profile
Table Hoffman-la-roche Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Ferring pharmaceuticals Profile
Table Ferring pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Lundbeck Profile
Table Lundbeck Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Cangene Profile
Table Cangene Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Glaxosmithkline Profile
Table Glaxosmithkline Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Janssen-cilag Profile
Table Janssen-cilag Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Kedrion biopharmaceuticals, spa Profile
Table Kedrion biopharmaceuticals, spa Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Protein Drugs Production by Type (2014-2019)
Table Global Protein Drugs Production Market Share by Type (2014-2019)
Figure Global Protein Drugs Production Market Share by Type in 2018
Table Global Protein Drugs Revenue by Type (2014-2019)
Table Global Protein Drugs Revenue Market Share by Type (2014-2019)
Figure Global Protein Drugs Revenue Market Share by Type in 2018
Table Protein Drugs Price by Type (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Cytokines (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Antibodies (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Blood products (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Peptide antibiotics (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Vaccines (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Enzymes (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Peptide hormones (2014-2019)
Table Global Protein Drugs Consumption by Application (2014-2019)
Table Global Protein Drugs Consumption Market Share by Application (2014-2019)
Table Global Protein Drugs Consumption of Application 1 (2014-2019)
Table Global Protein Drugs Consumption of Application 2 (2014-2019)
Table Global Protein Drugs Consumption of Application 3 (2014-2019)
Table Global Protein Drugs Consumption by Region (2014-2019)
Table Global Protein Drugs Consumption Market Share by Region (2014-2019)
Table United States Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Europe Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table China Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Japan Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table India Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Central and South America Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Global Protein Drugs Production by Region (2014-2019)
Table Global Protein Drugs Production Market Share by Region (2014-2019)
Figure Global Protein Drugs Production Market Share by Region (2014-2019)
Figure Global Protein Drugs Production Market Share by Region in 2018
Table Global Protein Drugs Revenue by Region (2014-2019)
Table Global Protein Drugs Revenue Market Share by Region (2014-2019)
Figure Global Protein Drugs Revenue Market Share by Region (2014-2019)
Figure Global Protein Drugs Revenue Market Share by Region in 2018
Table Global Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table China Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table India Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Protein Drugs Production, Revenue, Price and Gross Margin
Figure Protein Drugs Product Picture
Table Global Protein Drugs Production and CAGR (%) Comparison by Type
Table Profile of Cytokines
Table Profile of Antibodies
Table Profile of Blood products
Table Profile of Peptide antibiotics
Table Profile of Vaccines
Table Profile of Enzymes
Table Profile of Peptide hormones
Table Protein Drugs Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Application 1
Table Profile of Application 2
Table Profile of Application 3
Figure Global Protein Drugs Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Europe Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Germany Protein Drugs Revenue and Growth Rate (2014-2026)
Figure UK Protein Drugs Revenue and Growth Rate (2014-2026)
Figure France Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Italy Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Spain Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Russia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Poland Protein Drugs Revenue and Growth Rate (2014-2026)
Figure China Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Japan Protein Drugs Revenue and Growth Rate (2014-2026)
Figure India Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Malaysia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Singapore Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Philippines Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Indonesia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Thailand Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Vietnam Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Central and South America Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Brazil Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Mexico Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Colombia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Protein Drugs Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Turkey Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Egypt Protein Drugs Revenue and Growth Rate (2014-2026)
Figure South Africa Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Nigeria Protein Drugs Revenue and Growth Rate (2014-2026)
Figure Global Protein Drugs Production Status and Outlook (2014-2026)
Table Global Protein Drugs Production by Player (2014-2019)
Table Global Protein Drugs Production Share by Player (2014-2019)
Figure Global Protein Drugs Production Share by Player in 2018
Table Protein Drugs Revenue by Player (2014-2019)
Table Protein Drugs Revenue Market Share by Player (2014-2019)
Table Protein Drugs Price by Player (2014-2019)
Table Protein Drugs Manufacturing Base Distribution and Sales Area by Player
Table Protein Drugs Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Medimmune Profile
Table Medimmune Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Allergan Profile
Table Allergan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Affymax Profile
Table Affymax Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Protein sciences corporation Profile
Table Protein sciences corporation Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Mylan Profile
Table Mylan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Amgen Profile
Table Amgen Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Johnson & johnson Profile
Table Johnson & johnson Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Btg international Profile
Table Btg international Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Dendreon Profile
Table Dendreon Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Biotest pharmaceuticals Profile
Table Biotest pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Hospira Profile
Table Hospira Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Eisai Profile
Table Eisai Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Alexion pharmaceuticals Profile
Table Alexion pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Eli lilly Profile
Table Eli lilly Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Baxter healthcare Profile
Table Baxter healthcare Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Bio products laboratory Profile
Table Bio products laboratory Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Csl Profile
Table Csl Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-myers squibb Profile
Table Bristol-myers squibb Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Fresenius kabi Profile
Table Fresenius kabi Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Octapharma pharmazeutika produktionsges.m.b.h Profile
Table Octapharma pharmazeutika produktionsges.m.b.h Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Kamada Profile
Table Kamada Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Grifols biologicals Profile
Table Grifols biologicals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Bayer healthcare pharmaceuticals Profile
Table Bayer healthcare pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis Profile
Table Novartis Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Novo nordisk Profile
Table Novo nordisk Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Abbott laboratories Profile
Table Abbott laboratories Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Alcon Profile
Table Alcon Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Omrix biopharmaceuticals Profile
Table Omrix biopharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Biogen Profile
Table Biogen Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Nabi biopharmaceuticals (now biota pharmaceuticals) Profile
Table Nabi biopharmaceuticals (now biota pharmaceuticals) Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Profile
Table Merck Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Boehringer ingelheim Profile
Table Boehringer ingelheim Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Hoffman-la-roche Profile
Table Hoffman-la-roche Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Ferring pharmaceuticals Profile
Table Ferring pharmaceuticals Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Lundbeck Profile
Table Lundbeck Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Cangene Profile
Table Cangene Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Glaxosmithkline Profile
Table Glaxosmithkline Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Janssen-cilag Profile
Table Janssen-cilag Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Kedrion biopharmaceuticals, spa Profile
Table Kedrion biopharmaceuticals, spa Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Protein Drugs Production by Type (2014-2019)
Table Global Protein Drugs Production Market Share by Type (2014-2019)
Figure Global Protein Drugs Production Market Share by Type in 2018
Table Global Protein Drugs Revenue by Type (2014-2019)
Table Global Protein Drugs Revenue Market Share by Type (2014-2019)
Figure Global Protein Drugs Revenue Market Share by Type in 2018
Table Protein Drugs Price by Type (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Cytokines (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Antibodies (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Blood products (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Peptide antibiotics (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Vaccines (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Enzymes (2014-2019)
Figure Global Protein Drugs Production Growth Rate of Peptide hormones (2014-2019)
Table Global Protein Drugs Consumption by Application (2014-2019)
Table Global Protein Drugs Consumption Market Share by Application (2014-2019)
Table Global Protein Drugs Consumption of Application 1 (2014-2019)
Table Global Protein Drugs Consumption of Application 2 (2014-2019)
Table Global Protein Drugs Consumption of Application 3 (2014-2019)
Table Global Protein Drugs Consumption by Region (2014-2019)
Table Global Protein Drugs Consumption Market Share by Region (2014-2019)
Table United States Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Europe Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table China Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Japan Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table India Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Central and South America Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Protein Drugs Production, Consumption, Export, Import (2014-2019)
Table Global Protein Drugs Production by Region (2014-2019)
Table Global Protein Drugs Production Market Share by Region (2014-2019)
Figure Global Protein Drugs Production Market Share by Region (2014-2019)
Figure Global Protein Drugs Production Market Share by Region in 2018
Table Global Protein Drugs Revenue by Region (2014-2019)
Table Global Protein Drugs Revenue Market Share by Region (2014-2019)
Figure Global Protein Drugs Revenue Market Share by Region (2014-2019)
Figure Global Protein Drugs Revenue Market Share by Region in 2018
Table Global Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table China Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table India Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Protein Drugs Production, Revenue, Price and Gross Margin
